Cargando…

Drug Repositioning for Refractory Benign Tumors of the Central Nervous System

Drug repositioning (DR) is the process of identifying novel therapeutic potentials for already-approved drugs and discovering new therapies for untreated diseases. DR can play an important role in optimizing the pre-clinical process of developing novel drugs by saving time and cost compared with the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tamura, Ryota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455557/ https://www.ncbi.nlm.nih.gov/pubmed/37629179 http://dx.doi.org/10.3390/ijms241612997

Ejemplares similares

Fluvoxamine and Amantadine: Central Nervous System Acting Drugs Repositioned for COVID-19 as Early Intervention
por: Rejdak, Konrad, et al.
Publicado: (2022)

Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning
por: Morofuji, Yoichi, et al.
Publicado: (2020)

Machine Learning for the Detection and Segmentation of Benign Tumors of the Central Nervous System: A Systematic Review
por: Windisch, Paul, et al.
Publicado: (2022)

Drugs in Central Nervous System Disorders
por: Perry, Bruce D.
Publicado: (1985)

DrugCentral 2021 supports drug discovery and repositioning
por: Avram, Sorin, et al.
Publicado: (2020)

Nanomaterials for Drug Delivery to the Central Nervous System
por: Teleanu, Daniel Mihai, et al.
Publicado: (2019)

Rare Primary Central Nervous System Tumors
por: Kubicky, Charlotte Dai, et al.
Publicado: (2014)

Molecular pathology of tumors of the central nervous system
por: Kristensen, B W, et al.
Publicado: (2019)

Novel candidate drugs in anti-tumor necrosis factor refractory Crohn’s diseases: in silico study for drug repositioning
por: Kwak, Min Seob, et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
por: Laudisi, Federica, et al.
Publicado: (2020)

Central nervous system biomarkers for antiobesity drug development()
por: Ziauddeen, Hisham, et al.
Publicado: (2013)

Pathogen-inspired drug delivery to the central nervous system
por: McCall, Rebecca L, et al.
Publicado: (2014)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

Efficacy of Repositioning Therapy in Patients With Benign Paroxysmal Positional Vertigo and Preexisting Central Neurologic Disorders
por: Chen, Chih-Chung, et al.
Publicado: (2018)

Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review
por: Nepal, Gaurav, et al.
Publicado: (2022)

Pharmacokinetic Principles and Their Application to Central Nervous System Tumors
por: Straehla, Joelle P., et al.
Publicado: (2020)

Expanding the spectrum of “mesenchymal” tumors of the central nervous system
por: Pizzimenti, Cristina, et al.
Publicado: (2022)

Strategies for Enhanced Drug Delivery to the Central Nervous System
por: Dwibhashyam, V. S. N. M., et al.
Publicado: (2008)

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System
por: Crowe, Tyler P., et al.
Publicado: (2022)

Systems-level biomarkers identification and drug repositioning in colorectal cancer
por: Beklen, Hande, et al.
Publicado: (2021)

The Use of Central Nervous System Active Drugs During Pregnancy
por: Källén, Bengt, et al.
Publicado: (2013)

Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach
por: Pavan, Barbara, et al.
Publicado: (2008)

Astrocytes: the neglected stars in the central nervous system and drug addiction
por: Chen, Wenjun, et al.
Publicado: (2022)

Liquid biopsy for pediatric central nervous system tumors
por: Bonner, Erin R., et al.
Publicado: (2018)

The PCR-Based Diagnosis of Central Nervous System Tuberculosis: Up to Date
por: Takahashi, Teruyuki, et al.
Publicado: (2012)

Changing Trends in Computational Drug Repositioning
por: Yella, Jaswanth K., et al.
Publicado: (2018)

Review of Drug Repositioning Approaches and Resources
por: Xue, Hanqing, et al.
Publicado: (2018)

The Immunogenetics of Psoriasis and Implications for Drug Repositioning
por: Xu, Xuan, et al.
Publicado: (2017)

Drug repositioning in sarcomas and other rare tumors
por: Lee, Alex T.J., et al.
Publicado: (2016)

The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors
por: Rodriguez, Andrew, et al.
Publicado: (2023)

Repositioning Chairs in the Diagnosis and Treatment of Benign Paroxysmal Positional Vertigo - A Systematic Review
por: Abdulovski, Serkan, et al.
Publicado: (2021)

Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
por: Banno, Kouji, et al.
Publicado: (2015)

Tumors of the Central Nervous System: An Update
por: Mucignat-Caretta, Carla
Publicado: (2020)

Drug Penetration into the Central Nervous System: Pharmacokinetic Concepts and In Vitro Model Systems
por: Neumaier, Felix, et al.
Publicado: (2021)

Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning
por: Mohammadi, Elyas, et al.
Publicado: (2020)

Vascularisation of the central nervous system
por: Tata, Mathew, et al.
Publicado: (2015)

Mucormycosis of the Central Nervous System
por: Chikley, Amanda, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_00i4eeeajdmnl39mb507jqc051